Jul. 1 at 2:37 AM
$IIPR Just read the new SA article on
$IIPR and it does a good job laying out the bullish re-rating thesis. With medical cannabis now moving to Schedule III and the DEA hearings starting, tenants should see real cash flow improvement once the 280E tax burden eases. The stock’s still yielding over 12% with low leverage for a REIT and stable AFFO, yet the market hasn’t fully caught up to how much cleaner the story is getting. Bull case here has decent upside if the de-risking continues and multiple expansion kicks in. Feels like one of the better risk/reward setups in the space right now
